Want to join the conversation?
$LKQ lowered its 2016 organic revenue growth (parts and services) guidance to 5.5-7% from prior forecast of 6-8%. The company raised its 2016 adjusted EPS outlook to $1.79-1.87 from prior range of $1.76-1.86 and its cash flow from operations projection to $585-635MM from prior range of $575-625MM. $LKQ still sees capital expenditures of $200-225MM.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.